993 results on '"Vezinet, A."'
Search Results
102. Comment on: Antiretroviral treatment French guidelines 2013: economics influencing science
- Author
-
Morlat, P., Hoen, B., Blanc, Arnaud, Bonnet, Fabrice, Bourdillon, François, Brun-Vezinet, Françoise, Costagliola, Dominique, Dabis, François, Delobel, Pierre, Goujard, Cécile, Hoen, Bruno, Lortholary, Olivier, Mandelbrot, Laurent, Matheron, Sophie, Morlat, Philippe, Persiaux, Renaud, Poizot-Martin, Isabelle, Rey, David, Rouzioux, Christine, Simon, Anne, Taburet, Anne Marie, and Tattevin, Pierre
- Published
- 2014
- Full Text
- View/download PDF
103. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial
- Author
-
Dinh, Aurélien, primary, Ropers, Jacques, additional, Duran, Clara, additional, Davido, Benjamin, additional, Deconinck, Laurène, additional, Matt, Morgan, additional, Senard, Olivia, additional, Lagrange, Aurore, additional, Makhloufi, Sabrina, additional, Mellon, Guillaume, additional, de Lastours, Victoire, additional, Bouchand, Frédérique, additional, Mathieu, Emmanuel, additional, Kahn, Jean-Emmanuel, additional, Rouveix, Elisabeth, additional, Grenet, Julie, additional, Dumoulin, Jennifer, additional, Chinet, Thierry, additional, Pépin, Marion, additional, Delcey, Véronique, additional, Diamantis, Sylvain, additional, Benhamou, Daniel, additional, Vitrat, Virginie, additional, Dombret, Marie-Christine, additional, Renaud, Bertrand, additional, Perronne, Christian, additional, Claessens, Yann-Erick, additional, Labarère, José, additional, Bedos, Jean-Pierre, additional, Aegerter, Philippe, additional, Crémieux, Anne-Claude, additional, ATTAL-BEHAR, Julie, additional, BEAUNE, Sébastien, additional, CHINET, Thierry, additional, CUDENNEC, Tristan, additional, DE LAROCHE, Marine, additional, DE THEZY, Albane, additional, DUMOULIN, Jennifer, additional, DUPONT, Caroline, additional, FERCOT, Elise, additional, GIRAUT, Violaine, additional, GREFFE, Ségolène, additional, GRENET, Julie, additional, GUYOT, Caroline, additional, KAHN, Jean-Emmanuel, additional, LABRUNE, Sylvie, additional, LACHATRE, Marie, additional, MOULIAS, Sophie, additional, NALINE, Charlotte, additional, PEPIN, Marion, additional, ROUVEIX, Elisabeth, additional, SAHUT-D'IZARN, Marine, additional, SEFSSAFI, Abel, additional, TEILLET, Laurent, additional, BRU, Jean-Pierre, additional, GAILLAT, Jacques, additional, GAUTIER, Vincent, additional, JANSSEN, Cécile, additional, PAGANI, Leonardo, additional, VITRAT, Virginie, additional, ABDERRAHMANE, Malika, additional, CAMUSET, Juliette, additional, LEGALL, Catherine, additional, LONGUET-FLANDRES, Pascale, additional, MENN, Anne-Marie, additional, DE LASTOURS, Victoire, additional, LECRONIER, Marie, additional, PREVOST, Gwenolée, additional, BURDET, Charles, additional, DERRADJI, Ouda, additional, ESCAUT, Lelia, additional, HINGLAIS, Etienne, additional, LEBRAS, Philippe, additional, LEFEVRE, Edouard, additional, NOAILLON, Mathilde, additional, RABIER, Pauline, additional, RAPHAEL, Maurice, additional, TEICHER, Elina, additional, VERNY, Christiane, additional, VITTECOQ, Daniel, additional, WYPLOSZ, Benjamin, additional, BEN HAYOUN, Michèle, additional, BRUN-VEZINET, Françoise, additional, CASALINO, Enrique, additional, CHOQUET, Christophe, additional, DOMBRET, Marie-Christine, additional, DUVAL, Xavier, additional, HOUHOU, Nadhira, additional, JOLY, Véronique, additional, LESCURE, Xavier, additional, POGLIAGHI, Manuela, additional, RIOUX, Christophe, additional, YAZDANPANAH, Yazdan, additional, BARROS, Elsa, additional, BEGGA, Belinda, additional, BOUKOBZA, Sébastien, additional, BOUREDJI, Houria, additional, CHOUAHI, Imad, additional, DELACROIX, Isabelle, additional, FROISSART, Antoine, additional, GARRAIT, Valérie, additional, NGWEM, Elsa, additional, PHLIPPOTEAU, Catherine, additional, SALEHABADI, Sepehr, additional, TOPER, Cécile, additional, VINAS, Florent, additional, AMSILLI, Marie, additional, EPAULARD, Olivier, additional, PAVESE, Patricia, additional, PIERRE, Isabelle, additional, STAHL, Jean-Paul, additional, AULAGNIER, Jérôme, additional, CELERIER, Julie, additional, COJOCARIU, Roxana, additional, MATHIEU, Emmanuel, additional, RACHLINE, Charlotte, additional, SCHOINDRE, Yoland, additional, SENE, Thomas, additional, THIERRY, Christelle, additional, APARICIO, Caroline, additional, DELCEY, Véronique, additional, LOPES, Amanda, additional, MORGAND, Marjolaine, additional, SELLIER, Pierre, additional, SIMONEAU, Guy, additional, CHAKVETADZE, Catherine, additional, DIAMANTIS, Sylvain, additional, GAUTHIER, Arnaud, additional, JIDAR, Kaoutar, additional, JOURDAIN, Béatrice, additional, BOITIAUX, Jean-Francois, additional, DESCHAMPS, Patrick, additional, DEVAUD, Edouard, additional, PHILIPPE, Bruno, additional, CALIN, Ruxandra-Oana, additional, CHROBOCZEK, Tomasz, additional, DAVIDO, Benjamin, additional, DECONINCK, Laurène, additional, DE TRUCHIS, Pierre, additional, LAGRANGE, Aurore, additional, MAKHLOUFI, Sabrina, additional, MATT, Morgan, additional, MELLON, Guillaume, additional, SENARD, Olivia, additional, BENHAMOU, Daniel, additional, CHAPUZET, Claire, additional, CHAUFFREY, Laure, additional, ETIENNE, Manuel, additional, JOLY, Luc-Marie, additional, OBSTOY, Bérengère, additional, SALAUN, Mathieu, additional, THIBERVILLE, Luc, additional, TILLON, Julie, additional, BOLLENS, Diane, additional, BOTTERO, Julie, additional, CAMPA, Pauline, additional, COSQUERIC, Gäelle, additional, LEFEBVRE, Bénédicte, additional, OUAZENE, Zineb, additional, PACANOWSKI, Jérôme, additional, PATERON, Dominique, additional, VALIN, Nadia, additional, COMPAIN, Caroline, additional, CORDEL, Hugues, additional, DOUMENC, Benoit, additional, FOIS, Elena, additional, GAMBIER, Nicolas, additional, KHUONG, Marie-Aude, additional, PASQUALONI, Elisa, additional, and POUPARD, Marie, additional
- Published
- 2021
- Full Text
- View/download PDF
104. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an international AIDS Society-USA panel
- Author
-
Hirsch, Martin S., Gunthard, Huldrych F., Schapiro, Jonathan M., Brun-Vezinet, Francoise, Clotet, Bonaventura, Hammer, Scott M., Johnson, Victoria A., Kuritzkes, Daniel R., Mellors, John W., Pillay, Deenan, Yeni, Patrick G., Jacobsen, Donna M., and Richman, Douglas D.
- Subjects
Drug resistance in microorganisms -- Testing ,HIV infection -- Complications and side effects ,Practice guidelines (Medicine) -- Reports ,Health ,Health care industry - Published
- 2008
105. Hybrid Navigation Filters Performances Between GPS, Galileo and 5G TOA Measurements in Multipath Environment
- Author
-
Anne-Marie Tobie, Axel Garcia-Pena, Marion Aubault, Paul Thevenon, Jérémy Vezinet, Ecole Nationale de l'Aviation Civile (ENAC), Télécommunications Spatiales et Aéronautiques - Telecommunications for Space ant Aeronautics (TéSA), Laboratoire de recherche coopératif dans les télécommunications spatiales et aéronautiques (TESA), and Centre National d'Études Spatiales [Toulouse] (CNES)
- Subjects
Signal processing ,business.industry ,Computer science ,020206 networking & telecommunications ,02 engineering and technology ,Kalman filter ,Radio propagation ,Extended Kalman filter ,Time of arrival ,GNSS applications ,0202 electrical engineering, electronic engineering, information engineering ,Global Positioning System ,Electronic engineering ,business ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,Multipath propagation - Abstract
International audience; In this paper, the performance of different hybrid navigation filters exploiting GPS, Galileo and 5G Time Of Arrival (TOA) measurements in multipath environment are studied. For the realism of the study, realistic propagation channels must be considered and their impacts on the received signals processing must be accurately modelled. GNSS signal mathematical models in multipath environment have been analyzed for a long time. However, 5G mathematical models in a realistic multipath environment are still in its early stages of analysis. This article is divided in three main parts. The first part is dedicated to the identification of compliant GNSS and 5G signal propagation channel models; SCHUN is selected for GNSS and QuaDRiGa is selected for 5G. Based on this, the correlator output mathematical models for 5G signals and GNSS signals are derived. The second part tackles the accurate characterization of the pseudo range errors due to propagation channels shadowing and multipath effect as well as thermal noise. This step is required for the correct derivation of the navigation filters. Indeed, the study will focus on Extended Kalman Filters (EKF) and Unscented Kalman Filters (UKF); both assume a Gaussian distribution of the errors. Therefore, by optimally characterizing the errors, the performances of the filters are expected to be improved. The last part consists in validating through simulations the theory and mathematical models developed in the first and second parts.
- Published
- 2020
106. Characterization of Meaconing and its Impact on GNSS Receivers
- Author
-
Axel Garcia-Pena, Alexandre Chabory, Jérémy Vezinet, Benoit Roturier, Pierre Ladoux, Maxandre Coulon, Christophe Macabiau, Philippe Estival, Ecole Nationale de l'Aviation Civile (ENAC), Direction des services de la navigation aérienne de la DGAC (DSNA), and Direction Générale de l'Aviation Civile (DGAC)
- Subjects
Repeater ,Mathematical model ,Computer science ,020209 energy ,Pseudorange ,02 engineering and technology ,Signal ,Physics::Geophysics ,symbols.namesake ,GNSS applications ,Physics::Space Physics ,0202 electrical engineering, electronic engineering, information engineering ,symbols ,Electronic engineering ,Trajectory ,020201 artificial intelligence & image processing ,Doppler effect ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,Multipath propagation - Abstract
International audience; This article offers a new characterization of GNSS meaconing and its impact on GNSS receivers through mathematical modelsand simulations.First, general mathematical models of the received signal at a receiver’s correlators input and output in nominal conditions thenin presence of a GNSS repeater are derivated. Then, the impact of a GNSS repeater is mathematically determined throughsimulations on a virtual GNSS receiver having various trajectories (static, pedestrian, car and airborne) for both realistic anddegraded satellites and repeater configurations.In this article, the received meaconing power, code delay and phase shift are computed with reason to the authentic signal’sparameters. A 3D multipath error envelope is introduced to obtain maximal and minimal code delay estimation error accordingto multipath’s delay and Doppler difference. A model of the newCN0cause by the meaconer is also given in this article.Simulations in nominal and degraded satellites configurations for various trajectories allow to emphasize the impact of themeaconer’s Doppler difference on the pseudorange and positioning errors. The impact of meaconing also is also proven togreatly depends on the GNSS receiver’s trajectory and velocity
- Published
- 2020
107. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
- Author
-
Alexandra Beurton, Abdelmalek Abdelkrim, Nicolas Bréchot, Alexandre Elabbadi, Juliette Chommeloux, Martin De Sarcus, Thomas Urbina, Elodie Baron, Thibaut Schoell, Paris Meng, Charlotte Du Fayet De La Tour, Sofica Marin, Victoria Lepere, Elise Morawiec, Eric Maury, Bertrand Guidet, Pierre Romain Delmotte, Enora Berti, Pierre Bay, Alain Combes, Hafid Ait Oufella, Muriel Fartoukh, Jean Luc Baudel, Samia Abbas, David Levy, Matthieu Turpin, David Hajage, Cossimo D'Alessandro, Pascal Leprince, Corinne Vezinet, Charles Edouard Luyt, Robin Deleris, Martin Dres, Jean Michel Constantin, Alexandre Demoule, Marc Pineton de Chambrun, Mona Assefi, Guillaume Hékimian, Cyrielle Desnos, Pierre Demondion, Guillaume Voiriot, Bao Long Nguyen, Arthur James, Harold Bonvallot, Safaa Nemlaghi, Nathalie Nardonne, Julien Mayaux, Vincent Bonny, Guillaume Lebreton, Cyril Quemeneur, Sara Virolle, Emmanuelle Guerin, Matthieu Schmidt, Aude Gibelin, Julien Le Marec, Charles Juvin, Guillaume Savary, Jean Remi Lavillegrand, Antoine Monsel, Jeremy Arzoine, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de cardiologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Service de Réanimation Médicale [CHU Pitié-Salpétrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Chirurgie cardiaque et thoracique [CHU Pitié-Salpêtrière], Service d'Anesthésie réanimation [CHU Pitié-Salpêtrière], Departement Hospitalo- Universitaire - Inflammation, Immunopathologie, Biothérapie [Paris] (DHU - I2B), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière] (I3), CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Service de Réanimation et USC Médico-Chirurgicale [CHU Tenon], CHU Tenon [AP-HP], Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service de Pneumologie, Médecine Intensive et Réanimation - R3S [CHU Pitié-Salpêtrière] (SPMIR-R3S), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), Service de Pneumologie et Réanimation Médicale [CHU Pitié-Salpêtrière] (Département ' R3S '), Neurophysiologie Respiratoire Expérimentale et Clinique, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Service de Réanimation Médicale [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de Pneumologie - R3S [CHU Pitié-Salpêtrière] (SPMIR-R3S), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases [IHU ICAN], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-CHU Saint-Antoine [AP-HP], Service de Réanimation et USC Médico-Chirurgicale = Médecine intensive réanimation [CHU Tenon], Service de Médecine Intensive et Réanimation - R3S [CHU Pitié-Salpêtrière], and Neurophysiologie Respiratoire Expérimentale et Clinique (UMRS 1158)
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,ARDS ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Pneumonia, Viral ,Context (language use) ,Betacoronavirus ,03 medical and health sciences ,Extracorporeal Membrane Oxygenation ,0302 clinical medicine ,Intensive care ,medicine ,Extracorporeal membrane oxygenation ,Humans ,030212 general & internal medicine ,Pandemics ,Survival rate ,Retrospective Studies ,Respiratory Distress Syndrome ,SARS-CoV-2 ,Proportional hazards model ,business.industry ,COVID-19 ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Survival Rate ,Intensive Care Units ,surgical procedures, operative ,030228 respiratory system ,Respiratory failure ,Emergency medicine ,Female ,France ,Coronavirus Infections ,business - Abstract
Summary Background Patients with COVID-19 who develop severe acute respiratory distress syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and death. The efficacy of extracorporeal membrane oxygenation (ECMO) for patients with severe ARDS in the context of COVID-19 is unclear. We aimed to establish the clinical characteristics and outcomes of patients with respiratory failure and COVID-19 treated with ECMO. Methods This retrospective cohort study was done in the Paris–Sorbonne University Hospital Network, comprising five intensive care units (ICUs) and included patients who received ECMO for COVID-19 associated ARDS. Patient demographics and daily pre-ECMO and on-ECMO data and outcomes were collected. Possible outcomes over time were categorised into four different states (states 1–4): on ECMO, in the ICU and weaned off ECMO, alive and out of ICU, or death. Daily probabilities of occupation in each state and of transitions between these states until day 90 post-ECMO onset were estimated with use of a multi-state Cox model stratified for each possible transition. Follow-up was right-censored on July 10, 2020. Findings From March 8 to May 2, 2020, 492 patients with COVID-19 were treated in our ICUs. Complete day-60 follow-up was available for 83 patients (median age 49 [IQR 41–56] years and 61 [73%] men) who received ECMO. Pre-ECMO, 78 (94%) patients had been prone-positioned; their median driving pressure was 18 (IQR 16–21) cm H2O and PaO2/FiO2 was 60 (54–68) mm Hg. At 60 days post-ECMO initiation, the estimated probabilities of occupation in each state were 6% (95% CI 3–14) for state 1, 18% (11–28) for state 2, 45% (35–56) for state 3, and 31% (22–42) for state 4. 35 (42%) patients had major bleeding and four (5%) had a haemorrhagic stroke. 30 patients died. Interpretation The estimated 60-day survival of ECMO-rescued patients with COVID-19 was similar to that of studies published in the past 2 years on ECMO for severe ARDS. If another COVID-19 outbreak occurs, ECMO should be considered for patients developing refractory respiratory failure despite optimised care. Funding None.
- Published
- 2020
108. Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19
- Author
-
Arnaud Fekkar, C. Poignon, A. Lampros, Corinne Vezinet, M. Blaize, and Antoine Monsel
- Subjects
Microbiology (medical) ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Critically ill ,business.industry ,Pulmonary Fusariosis ,medicine.medical_treatment ,General Medicine ,medicine.disease ,Article ,Pneumonia ,Infectious Diseases ,Pandemic ,Medicine ,Intubation ,Immunocompetence ,business ,Intensive care medicine - Published
- 2020
109. Large Oxygen and hafnium isotopic variations in zircon from the Saglek Block (North Atlantic Craton) document reworking of mature supracrustal rocks as early as 3.5 Ga
- Author
-
Yan Luo, Graham Pearson, Emilie Thomassot, Chiranjeeb Sarkar, Vezinet Adrien, and Richard A. Stern
- Subjects
Craton ,geography ,geography.geographical_feature_category ,chemistry ,Block (telecommunications) ,Geochemistry ,chemistry.chemical_element ,Oxygen ,Geology ,Zircon ,Hafnium - Abstract
The most ancient rocks in the geological record provide insights into the processes that shaped the evolution and composition of the first continental masses. Due to both the scarcity and the polymetamorphic history of exposed Eoarchean (>3.5 Ga) crust, the study of early geodynamic processes is very challenging and most of our knowledge has been learned from only a few localities on Earth.The present study focuses on felsic meta-igneous rock from the Saglek Block (North Atlantic Craton), a locality where recent zircon U-Pb dating studies indicate earliest crust formation in the Eoarchean (Komiya et al., 2017; Sałacińska et al., 2018; Vezinet et al., 2018). We performed in situ oxygen isotopes measurement (SIMS analyses) in zircon grains that have been carefully selected from CL-imaging for the good preservation of their internal structure and for their pristine composition in rare Earth element. We then performed U-Pb/Hf isotopes by laser ablation split stream (LASS)-ICP-MS. The results indicate 3 distinct crystallization events: (1) an Eoarchean event at ca 3.86 Ga; (2) an early Paleoarchean metamorphic event at ca. 3.5 Ga, and (3) a Neoarchean event (ca. 2.7-2.8 Ga) with zircon domains showing complex zoned overgrowths. While the 3.86 Ga magmatic domains display mantle-like δ18O(+4.9±0.2‰ to +6.8.0±0.2‰, n=30), large O-isotope fractionation (δ18Ovalues up to +9‰) characterise the Paleoarchean metamorphic event. Such elevated δ18O signatures provide unequivocal evidence for hydrosphere–crust interactions and reworking processes resulting in metamorphic zircon growth at ca. 3.5 Ga, namely 1 Ga before the Archean-Proterozoic transition (Vezinet et al., 2019).Interestingly, the two oldest age groups have chondritic to sub-chondritic εHfi values: +1.0 ± 2.2 to –5.5 ± 1.8 whereas large variations in Hf isotope composition (εHfi value from –11.2 ± 2.5 to –20.3 ± 1.5) are found in the 2.8–2.7 Ga zircon domains. Such intra-sample heterogeneities implies a significant perturbation of Hf-isotope composition during metamorphic events related to mixing of fluid with inherited (older) Hf isotope source. In the light of these results, we will discuss the potential consequences of isotope perturbation on whole-rock isochrones interpretation. Komiya, T., et al. "A prolonged granitoid formation in Saglek Block, Labrador: Zonal growth and crustal reworking of continental crust in the Eoarchean." Geoscience Frontiers 8.2 (2017): 355-385.Sałacińska, A., et al. "Complexity of the early Archean Uivak Gneiss: Insights from Tigigakyuk Inlet, Saglek Block, Labrador, Canada and possible correlations with south West Greenland." Precambrian Res. 315 (2018): 103-119.Vezinet, A, et al. "Hydrothermally-altered mafic crust as source for early Earth TTG: Pb/Hf/O isotope and trace element evidence in zircon from TTG of the Eoarchean Saglek Block, N. Labrador. EPSL 503 (2018): 95-107.Vezinet, A., et al. "Extreme δ18O signatures in zircon from the Saglek Block (North Atlantic Craton) document reworking of mature supracrustal rocks as early as 3.5 Ga." Geology 47.7 (2019): 605-608.
- Published
- 2020
110. First lower hybrid current drive experiments on the WEST tokamak
- Author
-
West Team, A. Ekedahl, D. Vezinet, M. Goniche, J. P. Gunn, Jorge Morales, X. Regal-Mezin, Nicolas Fedorczak, C. Desgranges, F. Saint-Laurent, C. Reux, C. Christopher Klepper, Jérôme Bucalossi, Clarisse Bourdelle, R. J. Dumont, J.F. Artaud, Lena Delpech, P. Moreau, O. Meyer, Didier Mazon, Patrick Maget, C. Gil, P. Devynck, J. Garcia, Rémy Nouailletas, and Y. Peysson
- Subjects
Tokamak ,Materials science ,Divertor ,chemistry.chemical_element ,Electron ,Tungsten ,law.invention ,chemistry ,law ,Electron temperature ,Current (fluid) ,Atomic physics ,Reflection coefficient ,Voltage - Abstract
The first lower hybrid current drive experiments in the full tungsten WEST tokamak are reported. Good wave coupling is found at rather low plasma current (q95∼4.3) and medium density (ne∼3×1019m-3). Reflection coefficient is in agreement with the expectation from the linear theory of coupling. With low reflection coefficients, 5MW was coupled for 2 seconds. High central electron temperature, up to 5keV, is achieved at ne = 3-4×1019m-3. Flat and even hollow profiles of tungsten density are derived from the bolometry diagnostic. The stored thermal energy follows the H96-P scaling law with very slight degradation with density. The current drive efficiency has been assessed in low loop voltage (VL∼0.15V) discharges. Low plasma current operation and rather high effective charge (Zeff∼3) lead to modest current drive efficiency (ƞ = 0.5-0.65 × 1019 A.W−1m-2). Long pulse operation (∼30s) with high LHCD power (PLH=2.7MW) is achieved with stationary parameters, in particular electron and impurity densities, with the upper water-cooled tungsten divertor.
- Published
- 2020
111. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism
- Author
-
Nijhuis, Monique, Van Maarseveen, Noortje M., Lastere, Stephane, Schipper, Pauline, Coakley, Eoin, Glass, Barbel, Rovenska, Mirka, De Jong, Dorien, Chappey, Colombe, Goedegebuure, Irma W., Heilek-Snyder, Gabrielle, Dulude, Dominic, Cammack, Nick, Brakier-Gingras, Lea, Konvalinka, Jan, Parkin, Neil, Krausslich, Hans-Georg, Brun-Vezinet, Francoise, and Boucher, Charles A.B.
- Subjects
HIV infection -- Care and treatment ,Protease inhibitors -- Usage - Abstract
ABSTRACT Background HIV protease inhibitor (PI) therapy results in the rapid selection of drug resistant viral variants harbouring one or two substitutions in the viral protease. To combat PI resistance [...]
- Published
- 2007
112. Development and Test of a 400-kV PFN Marx With Compactness and Rise Time Optimization
- Author
-
A. Loyen, R. Vezinet, F. Lassalle, T. Chanconie, Alain Morell, B. Roques, and Martial Toury
- Subjects
010302 applied physics ,Pulse repetition frequency ,Nuclear and High Energy Physics ,Pulse forming network ,Materials science ,business.industry ,Condensed Matter Physics ,01 natural sciences ,Marx generator ,010305 fluids & plasmas ,law.invention ,Inductance ,Capacitor ,Optics ,law ,Rise time ,0103 physical sciences ,business ,Diode ,Voltage - Abstract
Repetitive high-voltage square pulses are of great importance for producing long-pulse electron beams and high-power microwaves. One of possible technologies for the generation of such pulses is a Marx generator using pulse forming network (PFN) stages, often combined with a pulse sharpening technique to reduce the rise time to a few nanoseconds (peaking stage). This paper presents an innovative design, named the “zigzag design,” for the optimization of the compactness and of the rise time of 400-kV–85-ns PFN-Marx. Thanks to this design, the 16 stages of this generator, which delivers an open circuit output voltage of 720 kV, fit in a 650-mm length. For a slightly overmatched load ( $Z_{\mathrm {load}} = 100 ~\Omega$ ), the output voltage reaches 400 kV with a rise time as less as 5 ns. The inductance reduction associated with the innovative zigzag design, which allows this sharp rise time with no need for a peaking stage, is described. The 85-ns plateau duration of the pulse is given by the PFN construction of each stage, which is based on six ceramic capacitors (2.1 nF–45 kV) connected within a strip line. The 16 PFN stages are housed in a 360-mm diameter gas pressurized vessel. Burst mode operation for a duration of 10 s at a pulse repetition frequency of 100 Hz is reported, for a resistive load and for the electron beam diode of a X-band relativistic backward-wave oscillator (BWO). To reach further compactness, the BWO system is integrated on side of the generator vessel and a U-shaped gas pressurized line connects both systems through a compact conical vacuum insulator.
- Published
- 2018
113. Training for Lung Ultrasound Score Measurement in Critically Ill Patients
- Author
-
Jean-Jacques Rouby, Charlotte Arbelot, Yuzhi Gao, Mao Zhang, Jie Lv, Youzhong An, Wang Chunyao, Du Bin, Carmen Silvia Valente Barbas, Felippe Leopoldo Dexheimer Neto, Fabiola Prior Caltabeloti, Emidio Lima, Andres Cebey, Sébastien Perbet, Jean-Michel Constantin, Hélène Brisson, Romain Deransy, Corinne Vezinet, Pierre Garçon, Nabil El Hadj Kacem, Denis Lemesle, Antoine Monsel, Qin Lu, Olivier Langeron, Frédérick Gay, Bruno Lucena, Luiz Malbouisson, Maria José Carvalho Carmona, Julio Neves, Paulo de Tarso Roth Dalcin, Guilherme de Paula Pinto Schettino, Alberto Biestro, Davi Cristovao, and Jorge Salluh
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Critically ill ,business.industry ,MEDLINE ,030208 emergency & critical care medicine ,Critical Care and Intensive Care Medicine ,Lung ultrasound ,03 medical and health sciences ,0302 clinical medicine ,Text mining ,030228 respiratory system ,Correspondence ,medicine ,Intensive care medicine ,business - Published
- 2018
114. Antiretroviral Therapy and Drug Resistance in HIV-2 Infection
- Author
-
Brun-Vezinet, Francoise, primary, Matheron, Sophie, additional, and Descamps, Diane, additional
- Published
- 2013
- Full Text
- View/download PDF
115. Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria
- Author
-
Antoine Monsel, Jean-Jacques Rouby, Kevin Bihan, Corinne Vezinet, Olivier Langeron, Qin Lu, Xiao Lu, Noël Zahr, Jean-François Bertholon, Marie-Hélène Becquemin, and Charlotte Arbelot
- Subjects
Adult ,Male ,0301 basic medicine ,Microbiology (medical) ,medicine.medical_treatment ,030106 microbiology ,Urine ,Diluent ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Pharmacokinetics ,Drug Resistance, Multiple, Bacterial ,Administration, Inhalation ,medicine ,Humans ,Pharmacology (medical) ,Prospective Studies ,Lung ,Saline ,health care economics and organizations ,Aged ,Aerosols ,Pharmacology ,Cross-Over Studies ,Chromatography ,Inhalation ,Colistin ,Chemistry ,Nebulizers and Vaporizers ,Pneumonia, Ventilator-Associated ,Middle Aged ,Anti-Bacterial Agents ,Nebulizer ,Infectious Diseases ,030228 respiratory system ,Female ,Colistimethate ,medicine.drug - Abstract
Objectives Nebulized colistimethate sodium (CMS) can be used to treat ventilator-associated pneumonia caused by MDR bacteria. The influence of the diluent volume of CMS on aerosol delivery has never been studied. The main objectives of the study were to compare aerosol particle characteristics and plasma and urine pharmacokinetics between two diluent volumes in patients treated with nebulized CMS. Methods A crossover study was conducted in eight patients receiving nebulized CMS every 8 h. After inclusion, nebulization started with 4 million international units (MIU) of CMS diluted either in 6 mL (experimental dilution) or in 12 mL (recommended dilution) of normal saline in a random order. For each diluent volume, CMS aerosol particle sizes were measured and plasma and urine samples were collected every 2 h. Nebulization time and stability of colistin in normal saline were assessed. Results The mass median aerodynamic diameters were 1.4 ± 0.2 versus 0.9 ± 0.2 μm (P
- Published
- 2018
116. Effect of metamorphic overprint on early Earth isotopic compositions: the case study of Saglek Block (Labrador, Canada)
- Author
-
Vezinet, Adrien, primary, Thomassot, Emilie, additional, and Pearson, D., additional
- Published
- 2021
- Full Text
- View/download PDF
117. Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (the GUESS study)
- Author
-
Zolopa, Andrew R., Lazzeroni, Laura C., Rinehart, Alex, Vezinet, Francoise Brun, Clavel, Francois, Collier, Ann, Conway, Brian, Gulick, Roy M., Holodniy, Mark, Perno, Carlo-Frederico, Shafer, Robert W., Richman, Douglas D., Wainberg, Mark A., and Kuritzkes, Daniel R.
- Subjects
Lamivudine -- Dosage and administration ,HIV infection -- Drug therapy ,HIV infection -- Case studies ,Antiviral agents -- Dosage and administration ,Health ,Health care industry - Published
- 2005
118. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
- Author
-
Schmidt, Matthieu, primary, Hajage, David, additional, Lebreton, Guillaume, additional, Monsel, Antoine, additional, Voiriot, Guillaume, additional, Levy, David, additional, Baron, Elodie, additional, Beurton, Alexandra, additional, Chommeloux, Juliette, additional, Meng, Paris, additional, Nemlaghi, Safaa, additional, Bay, Pierre, additional, Leprince, Pascal, additional, Demoule, Alexandre, additional, Guidet, Bertrand, additional, Constantin, Jean Michel, additional, Fartoukh, Muriel, additional, Dres, Martin, additional, Combes, Alain, additional, Luyt, Charles-Edouard, additional, Hekimian, Guillaume, additional, Brechot, Nicolas, additional, Pineton de Chambrun, Marc, additional, Desnos, Cyrielle, additional, Arzoine, Jeremy, additional, Guerin, Emmanuelle, additional, Schoell, Thibaut, additional, Demondion, Pierre, additional, Juvin, Charles, additional, Nardonne, Nathalie, additional, Marin, Sofica, additional, D'Alessandro, Cossimo, additional, Nguyen, Bao-Long, additional, Quemeneur, Cyril, additional, James, Arthur, additional, Assefi, Mona, additional, Lepere, Victoria, additional, Savary, Guillaume, additional, Gibelin, Aude, additional, Turpin, Matthieu, additional, Elabbadi, Alexandre, additional, Berti, Enora, additional, Vezinet, Corinne, additional, Bonvallot, Harold, additional, Delmotte, Pierre-Romain, additional, De Sarcus, Martin, additional, Du Fayet De La Tour, Charlotte, additional, Abbas, Samia, additional, Maury, Eric, additional, Baudel, Jean-Luc, additional, Lavillegrand, Jean-Remi, additional, Ait Oufella, Hafid, additional, Abdelkrim, Abdelmalek, additional, Urbina, Thomas, additional, Virolle, Sara, additional, Deleris, Robin, additional, Bonny, Vincent, additional, Le Marec, Julien, additional, Mayaux, Julien, additional, and Morawiec, Elise, additional
- Published
- 2020
- Full Text
- View/download PDF
119. French National sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002
- Author
-
Descamps, Diane, Chaix, Marie-Laure, Andre, Patrice, Brodard, Veronique, Cottalorda, Jacqueline, Deveau, Christiane, Harzic, Martine, Ingrand, Didier, Izopet, Jacques, Kohli, Evelyne, Masquelier, Bernard, Poggi, Cecile, Palmer, Pierre, Mouajjah, Said, Pellegrin, Isabelle, Plantier, Jean-Christophe, Ruffault, Annick, Rogez, Sylvie, Meyer, Laurence, Schneider, Veronique, Brun-Vezinet, Francoise, Costagliola, Dominique, Rouzioux, Christine, Signori-Schmuck, Anne, Tamalet, Catherine, and Wirden, Marc
- Subjects
HIV infection -- Drug therapy ,Antiviral agents -- Research ,Health - Abstract
The frequency of genotypic antiretroviral resistance and the spread of non-B subtypes in patients with primary HIV-1 infection (2001-02) and in treatment-naive chronically HIV-infected patients (2001) are studied. While, the frequency of HIV-1 resistance in untreated patients was not significantly higher in 2001-2002, the prevalence of non-B subtypes is increasing.
- Published
- 2005
120. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes
- Author
-
Reigadas, S., Marcelin, A. G., Houssaïni, A., Yerly, S., Descamps, D., Plantier, J. C., Ruffault, A., Amiel, C., Trabaud, M. A., Flandre, Philippe, Fleury, H., Masquelier, B., Roussel, C., Alloui, C., Leguillou-Guillemette, H., Bettinger, D., Pallier, C., Descamps, D., Brun-Vezinet, F., Peytavin, G., Masquelier, B., Pinson, P., Reigadas, S., Vallet, S., Poveda, J. D., Mirand, A., Krivine, A., Auvray, C., de Rougemont, A., Yerly, S., Signori-Schmuck, A., Bocket, L., Rogez, S., Tamalet, C., Schneider, V., Amiel, C., Bouvier-Alias, M., Montes, B., Schvoerer, E., Ferré, V., Chaix, M. L., Guinard, J., Haim-Boukobza, S., Soulié, C., Marcelin, A. G., Flandre, P., Assoumou, L., Calvez, V., Maillard, A., Morand-Joubert, L., Chaplain, C., Delaugerre, C., Bourlet, T., Bertsch, S., Plantier, J. C., Raymond, S., and Marque-Juillet, S.
- Published
- 2013
- Full Text
- View/download PDF
121. Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients
- Author
-
Larrouy, Lucile, Vivot, Alexandre, Charpentier, Charlotte, Bénard, Antoine, Visseaux, Benoit, Damond, Florence, Matheron, Sophie, Chene, Geneviève, Brun-Vezinet, Françoise, and Descamps, Diane
- Published
- 2013
- Full Text
- View/download PDF
122. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an international AIDS society--USA panel. (HIV/AIDS)
- Author
-
Hirsch, Martin S., Brun-Vezinet, Francoise, Clotet, Bonaventura, Conway, Brian, Kuritzkes, Daniel R., D'Aquila, Richard T., Demeter, Lisa M., Hammer, Scott M., Johnson, Victoria A., Loveday, Clive, Mellors, John W., Jacobsen, Donna M., and Richman, Douglas D.
- Subjects
HIV infection -- Care and treatment ,Drug resistance -- Genetic aspects ,Drug resistance -- Physiological aspects ,Clinical trials ,Antiviral agents -- Testing ,Health ,Health care industry - Published
- 2003
123. Rapid Communication: HIV-1 Protease and Reverse Transcriptase Mutation Patterns Responsible for Discordances Between Genotypic Drug Resistance Interpretation Algorithms
- Author
-
Ravela, Jaideep, Betts, Bradley J., Brun-Vezinet, Francoise, Smith, Kate, Schapiro, Jonathan M., Winslow, Dean L., Reid, Caroline, and Shafer, Robert W.
- Subjects
Reverse transcriptase -- Research ,Protease inhibitors -- Research ,Drug resistance -- Testing ,HIV patients -- Case studies ,Health - Published
- 2003
124. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.
- Author
-
Monique Nijhuis, Noortje M van Maarseveen, Stephane Lastere, Pauline Schipper, Eoin Coakley, Bärbel Glass, Mirka Rovenska, Dorien de Jong, Colombe Chappey, Irma W Goedegebuure, Gabrielle Heilek-Snyder, Dominic Dulude, Nick Cammack, Lea Brakier-Gingras, Jan Konvalinka, Neil Parkin, Hans-Georg Kräusslich, Francoise Brun-Vezinet, and Charles A B Boucher
- Subjects
Medicine - Abstract
BACKGROUND: HIV protease inhibitor (PI) therapy results in the rapid selection of drug resistant viral variants harbouring one or two substitutions in the viral protease. To combat PI resistance development, two approaches have been developed. The first is to increase the level of PI in the plasma of the patient, and the second is to develop novel PI with high potency against the known PI-resistant HIV protease variants. Both approaches share the requirement for a considerable increase in the number of protease mutations to lead to clinical resistance, thereby increasing the genetic barrier. We investigated whether HIV could yet again find a way to become less susceptible to these novel inhibitors. METHODS AND FINDINGS: We have performed in vitro selection experiments using a novel PI with an increased genetic barrier (RO033-4649) and demonstrated selection of three viruses 4- to 8-fold resistant to all PI compared to wild type. These PI-resistant viruses did not have a single substitution in the viral protease. Full genomic sequencing revealed the presence of NC/p1 cleavage site substitutions in the viral Gag polyprotein (K436E and/or I437T/V) in all three resistant viruses. These changes, when introduced in a reference strain, conferred PI resistance. The mechanism leading to PI resistance is enhancement of the processing efficiency of the altered substrate by wild-type protease. Analysis of genotypic and phenotypic resistance profiles of 28,000 clinical isolates demonstrated the presence of these NC/p1 cleavage site mutations in some clinical samples (codon 431 substitutions in 13%, codon 436 substitutions in 8%, and codon 437 substitutions in 10%). Moreover, these cleavage site substitutions were highly significantly associated with reduced susceptibility to PI in clinical isolates lacking primary protease mutations. Furthermore, we used data from a clinical trial (NARVAL, ANRS 088) to demonstrate that these NC/p1 cleavage site changes are associated with virological failure during PI therapy. CONCLUSIONS: HIV can use an alternative mechanism to become resistant to PI by changing the substrate instead of the protease. Further studies are required to determine to what extent cleavage site mutations may explain virological failure during PI therapy.
- Published
- 2007
- Full Text
- View/download PDF
125. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir
- Author
-
Descamps, Diane, Flandre, Philippe, Joly, Veronique, Meiffredy, Vincent, Peytavin, Gilles, Izopet, Jacques, Tamalet, Catherine, Ai-Feng Zeng, Harel, Marine, Lastere, Stephane, Aboulker, Jean-Pierre, Yeni, Patrick, and Brun-Vezinet, Francoise
- Subjects
Epidemiology -- Statistics ,Epidemiology -- Research ,HIV patients -- Drug therapy ,HIV patients -- Health aspects ,HIV patients -- Care and treatment ,HIV infection -- Prevention ,HIV infection -- Genetic aspects ,HIV infection -- Health aspects ,Gene mutations -- Physiological aspects ,Drug therapy -- Health aspects ,Drug therapy -- Analysis ,Zidovudine -- Genetic aspects ,Zidovudine -- Physiological aspects ,Stavudine -- Physiological aspects ,Lamivudine -- Physiological aspects ,Indinavir -- Physiological aspects ,AIDS (Disease) -- Research ,Health - Abstract
Research has been conducted on zidovudine resistance mutations. The role of these mutations in virologic response to treatment with zidovudine or stavudine in combination with lamivudine and indinavir has been investigated, and the results demonstrate that zidovudine resistance mutations do not preclude a durable response to treatment with a three-drug regimen in the patients.
- Published
- 2002
126. IMPACT OF PRESERVATION SOLUTION ON GRAFTS AND POSTOPERATIVE ORGAN FAILURES FOLLOWING LIVER TRANSPLANTATION: O16-0031
- Author
-
Brisson, H., Arbelot, C., Vezinet, C., Lu, Q., Eyraud, D., Savier, E., Parizot, C., Vaillant, J.-C., Hannoun, L., Gorochov, G., and Rouby, J.-J.
- Published
- 2012
127. Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen
- Author
-
Larrouy, Lucile, Charpentier, Charlotte, Landman, Roland, Capitant, Catherine, Chazallon, Corine, Yeni, Patrick, Peytavin, Gilles, Damond, Florence, Brun-Vezinet, Françoise, and Descamps, Diane
- Published
- 2011
- Full Text
- View/download PDF
128. Sensitivity and specificity of a rapid influenza diagnostic test in children and clinical utility during influenza A (H1N1) 2009 outbreak
- Author
-
Angoulvant, F, Bellettre, X, Houhou, N, Dexpert, J B, Morin, L, Siriez, J Y, Soole, F, de Lauzanne, A, Cohen, R, Brun-Vezinet, F, Alberti, C, and Mercier, J C
- Published
- 2011
- Full Text
- View/download PDF
129. Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)
- Author
-
Zazzi, M, Kaiser, R, Sönnerborg, A, Struck, D, Altmann, A, Prosperi, M, Rosen-Zvi, M, Petroczi, A, Peres, Y, Schülter, E, Boucher, C A, Brun-Vezinet, F, Harrigan, P R, Morris, L, Obermeier, M, Perno, C-F, Phanuphak, P, Pillay, D, Shafer, R W, Vandamme, A-M, van Laethem, K, Wensing, A MJ, Lengauer, T, and Incardona, F
- Published
- 2011
- Full Text
- View/download PDF
130. Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort
- Author
-
Thiébaut, Rodolphe, Matheron, Sophie, Taieb, Audrey, Brun-Vezinet, Francoise, Chêne, Geneviève, and Autran, Brigitte
- Published
- 2011
- Full Text
- View/download PDF
131. Hybrid Navigation Filters Performances Between GPS, Galileo and 5G TOA Measurements in Multipath Environment
- Author
-
Tobie, Anne-Marie, primary, Garcia-Pena, Axel, additional, Thevenon, Paul, additional, Vezinet, Jérémy, additional, and Aubault, Marion, additional
- Published
- 2020
- Full Text
- View/download PDF
132. Characterization of Meaconing and its Impact on GNSS Receivers
- Author
-
Coulon, Maxandre, primary, Chabory, Alexandre, additional, Garcia-Pena, Axel, additional, Vezinet, Jeremy, additional, Macabiau, Christophe, additional, Estival, Philippe, additional, Ladoux, Pierre, additional, and Roturier, Benoit, additional
- Published
- 2020
- Full Text
- View/download PDF
133. Large Oxygen and hafnium isotopic variations in zircon from the Saglek Block (North Atlantic Craton) document reworking of mature supracrustal rocks as early as 3.5 Ga
- Author
-
Thomassot, Emilie, primary, Adrien, Vezinet, additional, Pearson, Graham, additional, Stern, Richard, additional, Luo, Yan, additional, and Sarkar, Chiranjeeb, additional
- Published
- 2020
- Full Text
- View/download PDF
134. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
- Author
-
Hantz, Sébastien, Garnier-Geoffroy, Françoise, Mazeron, Marie-Christine, Garrigue, Isabelle, Merville, Pierre, Mengelle, Catherine, Rostaing, Lionel, Saint Marcoux, Franck, Essig, Marie, Rerolle, Jean-Philippe, Cotin, Sébastien, Germi, Raphaëlle, Pillet, Sylvie, Lebranchu, Yvon, Turlure, Pascal, Alain, Sophie, Herbein, Georges, Coaquette, Alain, Lafon, Marie Edith, Garrigue, Isabelle, Archimbaud, Christine, Henquell, Cécile, Peigue-Lafeuille, Hélène, Pothier, Pierre, Bour, Jean Baptiste, Cesaire, Raymond, Majioullah, Fatimah, Morand, Patrice, Germi, Raphaëlle, Morel-Baccard, Christine, Signori-Schmuck, Anne, Alain, Sophie, Hantz, Sébastien, Grosjean, Jérôme, Morfin-Sherpa, Florence, Billaud, Geneviève, Domenach, Vinca, Andre, Patrice, Milon, Marie Paule, Segondy, Michel, Foulongne, Vincent, Agius, Gérard, Beby-Defaux, Agnès, Pozzetto, Bruno, Pillet, Sylvie, Mansuy, Jean Michel, Mengelle, Catherine, Gaudio-Castelain, Sandrine, Ducancelle, Alexandra, Lunel, Françoise, Payan, Christopher, Gouarin, Stéphanie, Dewilde, Anny, Bressolette, Céline, Coste-Burel, Marianne, Imbert-Marcille, Berthe-Marie, Andreoletti, Laurent, Leveque, Nicolas, Venard, Véronique, Jeulin, Hélène, Minjolle, Sophie, Gueudin, Marie, Colimon, Ronald, Stoll-Keller, Françoise, Fafi-Kremer, Samira, Dubois, F., Gaudy, Catherine, Deny, Paul, Vezinet, Françoise Brun, Houhou, Nadira, Honderlick, Patrick, Mazeron, Marie Christine, Leruez-Ville, Marianne, Vaghefi, Parissa, Dussaix, Elisabeth, Agut, Henri, Boutolleau, David, Deback, Claire, Scieux, Catherine, Le Goff, Jérôme, Ducloux, Didier, Vanlemmens, Claire, Larosa, Fabrice, Neau-Cransac, M., Dromer, C., Rosier, Emmanuelle, Merville, Pierre, Douillet, Marine, Morel, Delphine, Moreau, Karine, Martin, Séverine, Billes, Marc-Alain, Milpied, Noel, Tabrizi, Reza, Vigouroux, Stéphane, Melot, Cyril, Deteix, Patrice, Heng, Anne-Elisabeth, Mackaya, Léandre, Casanova, Sandrine, Bay, Jacques-Olivier, Demeocq, François, Duee, Frédéric, Mousson, Christiane, Hillon, Patrick, Minello, Anne, Charve, Philippe, Tanter, Yves, Bayle, François, Janbon, Bénédicte, Borrel, Elisabeth, Boignard, Aude, Neron, Linda, Pison, Christophe, Saint-Raymond, Christel, Brion, Jean Paul, Cahn, Jean Yves, Bordessoule, Dominique, Turlure, Pascal, Bompart, Frédérica, Philippon, Céline, Essig, Marie, Aldigier, Jean-Claude, Rerolle, Jean Philippe, Dickson, Zarah, Leprivey, Valérie, Roger-Rolle, Florence, Piguet, Christophe, Marquet, Pierre, Francois, Bruno, Pouteil-Noble, Claire, Mialou, Valérie, Mourad, Georges, Mariat, Christophe, Cornillon, Jérôme, Tavernie-Tardy, Emmanuelle, Attal, M., Huynh, Anne, Rostaing, Lionel, Kamar, Nassim, Mencia, Danièle, Crognier, Laure, de Ligny, Bruno Hurault, Hazzan, Marc, Bordigoni, Pierre, Pall-Kondolff, Sandrine, Salmon, Alexandra, Clement, Laurence, Chevallier, Patrice, Le Gouill, Steven, Gastinne, Thomas, Delaunay, Jacques, Ayari, Sameh, Guillaume, Thierry, Mohty, Mohammed, Moreau, Philippe, Robin, Marie-Aude, Le Houerou, Claire, Giral, Magali, Papuchon, Emmanuelle, Pattier, Sabine, Treilhaud, Michèle, Camus, Christophe, Etienne, Isabelle, Moulin, Bruno, Caillard-Ohlmann, Sophie, Lioure, Bruno, Cojean, Nadine, Lutz, Patrick, Uettwiller, Françoise, Entz-Werle, Natacha, Laplace, Annegret, Buchler, Matthias, Lebranchu, Yvon, Barbet, Christelle, Fourchy, Dominique, Stern, Marc, Grenet, Dominique, Delahousse, Michel, Karras, Alexandre, Saliba, Faouzi, Ichai, Philippe, Dhedin, Nathalie, Vernant, Jean-Paul, Uzunov, Madalina, Barrou, Benoît, Glotz, Denis, Peraldi, Marie-Noëlle, Langner, Nathalie, and Ribaud, Patricia
- Published
- 2010
- Full Text
- View/download PDF
135. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France
- Author
-
Descamps, Diane, Chaix, Marie-Laure, Montes, Brigitte, Pakianather, Sophie, Charpentier, Charlotte, Storto, Alexandre, Barin, Francis, Dos Santos, Georges, Krivine, Anne, Delaugerre, Constance, Izopet, Jacques, Marcelin, Anne-Geneviève, Maillard, Anne, Morand-Joubert, Laurence, Pallier, Coralie, Plantier, Jean-Christophe, Tamalet, Catherine, Cottalorda, Jacqueline, Desbois, Delphine, Calvez, Vincent, Brun-Vezinet, Françoise, Masquelier, Bernard, Costagliola, Dominique, Alloui, C., Bettinger, D., Anies, G., Masquelier, B., Vallet, S., Henquell, C., Bouvier-Alias, M., DosSantos, G., Signori-Schmuck, A., Rogez, S., André, P., Tardy, J. C., Trabaud, M. A., Tamalet, C., Montes, B., Cottalorda, J., Descamps, D., Brun-Vézinet, F., Charpentier, C., Chaix, M. L., Desbois, D., Fourati, S., Marcelin, A. G., Calvez, V., Flandre, P., Morand-Joubert, L., Delaugerre, C., Ruffault, A., Maillard, A., Plantier, J. C., Bourlet, T., Saoudin, H., Izopet, J., and Barin, F.
- Published
- 2010
- Full Text
- View/download PDF
136. 105 Effects of a specifically-designed intensive care information system length of stay and mortality
- Author
-
Hélène, Brisson, Charlotte, Arbelot, Qin, Lu, Belaid, Bouhemad, Corinne, Vezinet, Liliane, Bodin, Marie, Movschin, and Jean-Jacques, Rouby
- Published
- 2010
- Full Text
- View/download PDF
137. Use of brain diffusion tensor imaging for the prediction of long-term neurological outcomes in patients after cardiac arrest: a multicentre, international, prospective, observational, cohort study
- Author
-
Velly, Lionel, Perlbarg, Vincent, Boulier, Thomas, Adam, Nicolas, Delphine, Sebastien, Luyt, Charles-Edouard, Battisti, Valentine, Torkomian, Gregory, Arbelot, Charlotte, Chabanne, Russell, Jean, Betty, Di Perri, Carol, Laureys, Steven, Citerio, Giuseppe, Vargiolu, Alessia, Rohaut, Benjamin, Bruder, Nicolas, Girard, Nadine, Silva, Stein, Cottenceau, Vincent, Tourdias, Thomas, Coulon, Olivier, Riou, Bruno, Naccache, Lionel, Gupta, Rajiv, Benali, Habib, Galanaud, Damien, Puybasset, Louis, Constantin, Jean, Chastre, Jean, Amour, Julien, Vezinet, Corine, Rouby, Jean-Jacques, Raux, Mathieu, Langeron, Olivier, Degos, Vincent, Bolgert, Francis, Weiss, Nicolas, Similowski, Thomas, Demoule, Alexandre, Duguet, Alexandre, Tollard, Eléonore, Veber, Benoit, Lotterie, Jean-Albert, Sanchez-Pena, Paola, Genestal, Michèle, Patassini, Mirko, Meng, Delphine, Md, Galanaud, Meng, Torkomian, Adam, N, Institut de Neurosciences de la Timone (INT), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Laboratoire d'Imagerie Biomédicale (LIB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [APHP]-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [APHP], CHU Clermont-Ferrand, Coma Science Group [Liege], Université de Liège, Neurointensive Care Unit, Ospedale S. Gerardo, Bicocca (University of Milan), Università degli Studi di Milano-Bicocca [Milano] (UNIMIB), Hôpital de la Timone [CHU - APHM] (TIMONE), Département d'Anesthésie-Réanimation [Toulouse], Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Service de Réanimation Médicale [CHU Bordeaux], CHU Bordeaux [Bordeaux]-Hôpital Pellegrin, Neuroinflammation: imagerie et thérapie de la sclérose en plaques, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [APHP], Massachusetts General Hospital [Boston], Imagerie médicale et quantitative, Institut National de la Santé et de la Recherche Médicale (INSERM), Velly, L, Perlbarg, V, Boulier, T, Adam, N, Delphine, S, Luyt, C, Battisti, V, Torkomian, G, Arbelot, C, Chabanne, R, Jean, B, Di Perri, C, Laureys, S, Citerio, G, Vargiolu, A, Rohaut, B, Bruder, N, Girard, N, Silva, S, Cottenceau, V, Tourdias, T, Coulon, O, Riou, B, Naccache, L, Gupta, R, Benali, H, Galanaud, D, Puybasset, L, Constantin, J, Chastre, J, Amour, J, Vezinet, C, Rouby, J, Raux, M, Langeron, O, Degos, V, Bolgert, F, Weiss, N, Similowski, T, Demoule, A, Duguet, A, Tollard, E, Veber, B, Lotterie, J, Sanchez Pena, P, Génestal, M, Patassini, M, Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance Publique - Hôpitaux de Marseille (APHM), Laboratoire d'Imagerie Fonctionnelle (LIF), Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR14-IFR49-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de Mathématiques et Applications - ENS Paris (DMA), École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA), Troubles du comportement alimentaire de l'adolescent (UMR_S 669), Université Paris-Sud - Paris 11 (UP11)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Dept. of Neurological and Behavioural Sciences, Siena, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre National de la Recherche Scientifique (CNRS), Réanimation Polyvalente, Service d’Anesthésie Réanimation, Service d'Anesthésie et de Réanimation 1, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Laboratoire d'Anesthésiologie, Université Pierre et Marie Curie - Paris 6 (UPMC), Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (CRICM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Inter-University Centre for Astronomy and Astrophysics [Pune] (IUCAA), Service de Neuroradiologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Neuropsycho-pharmacologie expérimentale, Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Centre National de la Recherche Scientifique (CNRS), Institut de cardiologie [CHU Pitié-Salpêtrière], Service de Cardiologie [CHU Pitié-Salpêtrière], Neurophysiologie Respiratoire Expérimentale et Clinique, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Neuroprotection du Cerveau en Développement / Promoting Research Oriented Towards Early Cns Therapies (PROTECT), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Neurologie [CHU Pitié-Salpêtrière], IFR70-CHU Pitié-Salpêtrière [AP-HP], Université Nice Sophia Antipolis - Faculté de Médecine (UNS UFR Médecine), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA), Service de Pneumologie et Réanimation Médicale [CHU Pitié-Salpêtrière] (Département ' R3S '), Service d'imagerie médicale [CHU Rouen], Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Service de réanimation médicale [CHU Rouen], Toulouse Neuro Imaging Center (ToNIC), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Réanimation, CHU Toulouse [Toulouse]-CHU Purpan, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Pôle Anesthésie Réanimation [CHU de Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Laboratoire d'Imagerie Biomédicale [Paris] (LIB), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Toulouse Mind & Brain Institut (TMBI), Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), École normale supérieure - Paris (ENS Paris), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Centre National de la Recherche Scientifique (CNRS)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Université Nice Sophia Antipolis (... - 2019) (UNS), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Purpan [Toulouse], Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL), and Service de neurologie 1 [CHU Pitié-Salpétrière]
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,Sensitivity and Specificity ,03 medical and health sciences ,0302 clinical medicine ,Belgium ,Predictive Value of Tests ,Fractional anisotropy ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,ComputingMilieux_MISCELLANEOUS ,Aged ,Receiver operating characteristic ,medicine.diagnostic_test ,[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior ,business.industry ,[SCCO.NEUR]Cognitive science/Neuroscience ,Brain ,[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences ,Electroencephalography ,030208 emergency & critical care medicine ,Magnetic resonance imaging ,Middle Aged ,Prognosis ,Magnetic Resonance Imaging ,Heart Arrest ,Cardiac arrest, MRI ,Diffusion Tensor Imaging ,Treatment Outcome ,Italy ,Predictive value of tests ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Female ,Observational study ,France ,Neurology (clinical) ,Nervous System Diseases ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,030217 neurology & neurosurgery ,Diffusion MRI ,Cohort study - Abstract
Summary Background Prediction of neurological outcome after cardiac arrest is a major challenge. The aim of this study was to assess whether quantitative whole-brain white matter fractional anisotropy (WWM-FA) measured by diffusion tensor imaging between day 7 and day 28 after cardiac arrest can predict long-term neurological outcome. Methods This prospective, observational, cohort study (part of the MRI-COMA study) was done in 14 centres in France, Italy, and Belgium. We enrolled patients aged 18 years or older who had been unconscious for at least 7 days after cardiac arrest into the derivation cohort. The following year, we recruited the validation cohort on the same basis. We also recruited a minimum of five healthy volunteers at each centre for the normalisation procedure. WWM-FA values were compared with standard criteria for unfavourable outcome, conventional MRI sequences (fluid-attenuated inversion recovery and diffusion-weighted imaging), and proton magnetic resonance spectroscopy. The primary outcome was the best achieved Glasgow-Pittsburgh Cerebral Performance Categories (CPC) at 6 months, dichotomised as favourable (CPC 1–2) and unfavourable outcome (CPC 3–5). Prognostication performance was assessed by the area under the receiver operating characteristic (ROC) curves and compared between groups. This study was registered with ClinicalTrials.gov, number NCT00577954. Findings Between Oct 1, 2006, and June 30, 2014, 185 patients were enrolled in the derivation cohort, of whom 150 had an interpretable multimodal MRI and were included in the analysis. 33 (22%) patients had a favourable neurological outcome at 6 months. Prognostic accuracy, as quantified by the area under the ROC curve, was significantly higher with the normalised WWM-FA value (area under the ROC curve 0·95, 95% CI 0·91–0·98) than with the standard criteria for unfavourable outcome or other MRI sequences. In a subsequent validation cohort of 50 patients (enrolled between April 1, 2015, and March 31, 2016), a normalised WWM-FA value lower than 0·91, set from the derivation cohort, had a negative predictive value of 71·4% (95% CI 41·9–91·6) and a positive predictive value of 100% (90·0–100), with 89·7% sensitivity (75·8–97·1) and 100% specificity (69·1–100) for the prediction of unfavourable outcome. Interpretation In patients who are unconscious 7 days after cardiac arrest, the normalised WWM-FA value, measured by diffusion tensor imaging, could be used to accurately predict neurological outcome at 6 months. This evidence requires confirmation from future large-scale trials with a strict protocol of withdrawal or limitation-of-care decisions and time window for MRI. Funding French Ministry of Health, French National Agency for Research, Italian Ministry of Health, and Regione Lombardia.
- Published
- 2018
138. Contamination of argon x-ray spectra by tungsten and other elements commonly found in tokamaks
- Author
-
D Vezinet, J. E. Rice, M Sertoli, J. W. Hughes, N. M. Cao, Matthew Reinke, and M. F. Gu
- Subjects
Physics ,Tokamak ,Argon ,chemistry ,law ,Analytical chemistry ,chemistry.chemical_element ,Tungsten ,Contamination ,Condensed Matter Physics ,X ray spectra ,Atomic and Molecular Physics, and Optics ,law.invention - Abstract
Emission lines which appear in the spectral ranges of ground state transitions from n = 2 levels in He- and H-like argon ions are discussed. X-ray transitions from elements commonly found in tokamaks (tungsten, molybdenum, iron and sulphur) which radiate in the wavelength range from 3700–4000 mÅ are identified by comparison with atomic structure calculations. Individual lines from tungsten charge states in the vicinity of Zn-like W44+ are documented, along with B-like Mo37+. The behaviour of line ratios as a function of electron temperature is examined, in support of the identifications.
- Published
- 2021
139. Insights into the complexity of crustal differentiation: K2O-poor leucosomes within metasedimentary migmatites from the Southern Marginal Zone of the Limpopo Belt, South Africa
- Author
-
Matthew Mayne, Adrien Vezinet, Gautier Nicoli, Gary Stevens, and Jean-François Moyen
- Subjects
Felsic ,010504 meteorology & atmospheric sciences ,Continental crust ,Geochemistry ,Partial melting ,Geology ,engineering.material ,010502 geochemistry & geophysics ,Anatexis ,Granulite ,01 natural sciences ,Residuum ,Geochemistry and Petrology ,Magma ,engineering ,Plagioclase ,0105 earth and related environmental sciences - Abstract
Differentiation of the continental crust is the result of complex interactions between a large number of processes, which govern partial melting of the deep crust, magma formation and segregation, and magma ascent to significantly higher crustal levels. The anatectic metasedimentary rocks exposed in the Southern Marginal Zone of the Limpopo Belt represent an unusually well-exposed natural laboratory where the portion of these processes that operate in the deep crust can be directly investigated in the field. The formation of these migmatites occurred via absent incongruent melting reactions involving biotite, which produced cm- to m-scale, K2O-poor garnet-bearing stromatic leucosomes, with high Ca/Na ratios relative to their source rocks. Field investigation combined with geochemical analyses, and phase equilibrium modelling designed to investigate some aspects of disequilibrium partial melting, show that the outcrop features and compositions of the leucosomes suggest several steps in their evolution: (1) Melting of a portion of the source, with restricted plagioclase availability due to kinetic controls, to produce a magma (melt + entrained peritectic minerals in variable proportions relative to melt); (2) Segregation of the magma at near peak metamorphic conditions into melt accumulation sites (MAS), a.k.a. future leucosome; (3a) Reequilibration of the magma with a portion of the bounding mafic residuum via chemical diffusion (H2O, K2O), which triggers the co-precipitation of quartz and plagioclase in the MAS; (3b) Extraction of melt dominated magma to higher crustal levels, leaving peritectic minerals entrained from the site of the melting reaction and the minerals precipitated in the MASs to form the leucosome in the source. The key mechanism controlling this behaviour is the kinetically induced restriction of the amount of plagioclase available to the melting reaction. This results in elevated melt H2O and K2O and chemical potential gradient for these components across the leucosome/mafic residuum contact. The combination of all of these processes accurately explains the composition of the K2O-poor leucosomes. These findings have important implications for our understanding of melt segregation in the lower crust and minimum melt residency time which, according to the chemical modelling is < 5 years. We demonstrate that in some migmatitic granulites, the leucosomes constitute a type of felsic refractory residuum, rather than evidence of failed magma extraction. This provides a new insight into the ways that source heterogeneity may control anatexis. This article is protected by copyright. All rights reserved.
- Published
- 2017
140. Current status of the design of the ITER bolometer diagnostic
- Author
-
A. Pataki, D. Hermann, G. Veres, Roger Reichle, L. C. Ingesson, L. Tatar, H. Meister, C. Gliss, G. Nadasi, J. Koll, F. Penzel, M. Kannamüller, T. Sehmer, U. Walach, and D. Vezinet
- Subjects
Stray light ,Computer science ,Mechanical Engineering ,Divertor ,Bolometer ,Mechanical engineering ,Collimator ,Port (circuit theory) ,Pinhole ,01 natural sciences ,010305 fluids & plasmas ,law.invention ,Printed circuit board ,Nuclear Energy and Engineering ,law ,0103 physical sciences ,General Materials Science ,010306 general physics ,Civil and Structural Engineering ,Electronic circuit - Abstract
The ITER bolometer diagnostic shall provide the measurement of the total radiation emitted from the plasma, a part of the overall energy balance. 550 lines-of-sight (LOS) will be installed in ITER observing the whole plasma from many different angles to enable reliable measurements and tomographic reconstructions of the spatially resolved radiation profile. The LOS are bundled in 71 individual cameras, which will be located behind blanket modules on the vacuum vessel wall, in five divertor cassettes, in two upper port plugs and in one equatorial port plug. For all major design issues solutions have been elaborated and will be presented. The design of collimators has been developed and tested on prototypes to provide an exact definition of the required viewing cones of about 1° while reliably reducing reflections, stray light and microwave stray radiation. A 3D-shaped ceramic printed circuit board is proposed to hold the sensor, orient it as desired, and provide good thermal contact as well as the bridge for electrically connecting external signal cables to the meanders on the sensor. The design of the camera housing for vacuum vessel and divertor cameras has been optimised for improved management of the thermal heat flow, supported by tests defining material properties and verifying analysis. Additionally, methods have been developed to derive the main design parameters of cameras and decide if pinhole or collimator type is more advantageous. Recently, the system-level design phase started and uses the achieved results to define interfaces and designs for the specific locations in ITER, with a focus on the vacuum-vessel cameras to finalise the interface with blanket modules.
- Published
- 2017
141. Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients
- Author
-
Landman, Roland, Damond, Florence, Gerbe, Juliette, Brun-Vezinet, Francoise, Yeni, Patrick, and Matheron, Sophie
- Published
- 2009
- Full Text
- View/download PDF
142. Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073)
- Author
-
Descamps, Diane, Joly, Véronique, Flandre, Philippe, Peytavin, Gilles, Meiffrédy, Vincent, Delarue, Séverine, Lastère, Stéphane, Aboulker, Jean-Pierre, Yeni, Patrick, and Brun-Vézinet, Françoise
- Published
- 2005
- Full Text
- View/download PDF
143. Fast primary store based on an Arkad’ev-Marx generator
- Author
-
Koval’chuk, B. M., Kremnev, V. V., Kim, A. A., Manylov, V. I., Lassalle, F., Avrillaud, G., Bayol, F., Cassany, B., Foussat, A., Kovacs, F., Lample, R., Léon, J. F., Monjaux, P., Morell, A., Roques, B., and Vezinet, R.
- Published
- 1997
- Full Text
- View/download PDF
144. One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?
- Author
-
Costagliola, Dominique, Damond, Florence, Palmer, Pierre, Rouzioux, Christine, and Brun-vezinet, Françoise
- Published
- 2008
- Full Text
- View/download PDF
145. High Prevalence of Hepatitis C Virus Infection and Predominance of Genotype 4 in Rural Gabon
- Author
-
Ndong-Atome, G. R., Makuwa, M., Ouwe-Missi-Oukem-Boyer, O., Pybus, O. G., Branger, M., Hello, S. Le, Boye-Cheik, S. B., Brun-Vezinet, F., Kazanji, M., Roques, P., and Bisser, S.
- Published
- 2008
- Full Text
- View/download PDF
146. Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients
- Author
-
Damond, Florence, Lariven, Sylvie, Roquebert, Benedicte, Males, Sylvia, Peytavin, Gilles, Morau, Genevieve, Toledano, Daniel, Descamps, Diane, Brun-Vezinet, Francoise, and Matheron, Sophie
- Published
- 2008
- Full Text
- View/download PDF
147. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France
- Author
-
Drylewicz, Julia, Matheron, Sophie, Lazaro, Estibaliz, Damond, Florence, Bonnet, Fabrice, Simon, François, Dabis, François, Brun-Vezinet, Françoise, Chêne, Geneviève, and Thiébaut, Rodolphe
- Published
- 2008
- Full Text
- View/download PDF
148. Evaluations of Acute and Sub-Acute Biological Effects of Narrowband and Moderate-Band High Power Electromagnetic Waves on Cellular Spheroids
- Author
-
Muriel Golzio, Marie-Pierre Rols, Elisabeth Bellard, Laure Gibot, Quentin Saurin, Alexandre Catrain, Jelena Kolosnjaj-Tabi, Thomas Chretiennot, R. Vezinet, Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), GRAMAT (DAM/GRAMAT), Direction des Applications Militaires (DAM), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
- Subjects
Electromagnetic field ,Quantitative Biology::Tissues and Organs ,[SDV]Life Sciences [q-bio] ,lcsh:Medicine ,Apoptosis ,02 engineering and technology ,Electromagnetic radiation ,Article ,Quantitative Biology::Cell Behavior ,03 medical and health sciences ,Membrane biophysics ,0302 clinical medicine ,Narrowband ,Adenosine Triphosphate ,Electromagnetic Fields ,Electromagnetism ,Electric field ,Spheroids, Cellular ,Humans ,lcsh:Science ,Cell Proliferation ,Physics ,Membrane Potential, Mitochondrial ,Multidisciplinary ,lcsh:R ,Cell Membrane ,Spheroid ,Temperature ,Signal Processing, Computer-Assisted ,Plasma ,Fibroblasts ,021001 nanoscience & nanotechnology ,HCT116 Cells ,Mitochondria ,Amplitude ,embryonic structures ,Biophysics ,lcsh:Q ,0210 nano-technology ,030217 neurology & neurosurgery - Abstract
International audience; High power electromagnetic signals can disrupt the functioning of electronic devices. As electromagnetism plays a role in cells homeostasis, such electromagnetic signals could potentially also alter some physiological processes. Herein we report on distinct biological parameters assessment after cellular spheroids exposure to high power electromagnetic signals, such as the ones used for defense applications. Signals effects were assessed in tumor cells spheroids and in normal human dermal fibroblasts spheroids, where macroscopic aspect, growth, plasma membrane integrity, induction of apoptosis, ATP content, and mitochondrial potential were investigated after spheroids exposure to high power electromagnetic signals. No significant effects were observed, indicating that 1.5 GHz narrowband electromagnetic fields with incident amplitude level of 40 kV/m, and 150 MHz moderate-band electric fields with an amplitude of 72.5 to approximately 200 kV/m, do not cause any significant alterations of assessed parameters. Electronic devices can stop operating in response to intense external electromagnetic signals. Electromagnetic environments, or more precisely intentional electromagnetic environments 1 , are among emerging approaches that could be used for defense applications. High power electromagnetic (HPEM) technology can be deployed to temporarily or permanently disrupt electronic devices or could even be used against the personnel 2. The HPEM systems that can be used to impair or destroy electronics and hardware 3 , and thus to black out the opponents electronic systems, operate in the range of tens of MHz to a few tens of GHz. Alternatively, HPEM signals (with frequencies of approximately 100 GHz and millimeter waves) could be used against personnel. This non-lethal directed-energy weapon, can heat the surface of its targets (e.g. heat people's skin) 2. Such non-lethal weapon system, also known as the Active Denial System, was developed by the U.S. military (https://jnlwp.defense. gov/Press-Room/Fact-Sheets/ArticleViewFactsheets/Article/577989/active-denial-technology-fact-sheet/ retrieved August 2018) and was designed for area denial, perimeter security and crowd control. Similar systems were also elaborated by Russia (https://www.popularmechanics.com/military/weapons/a7804/ why-russia-will-be-the-first-to-use-the-pain-ray-9833954/ retrieved August 2018) and China (http://en.people. cn/n3/2018/0205/c90000-9423875.html retrieved August 2018). High Power Microwave (HPM) and High Power Radio Frequency (HPRF) systems can radiate high power and short duration oscillatory pulses of electromagnetic fields. These pulses can exhibit different amplitudes, durations, frequency spectrums, as well as Pulse Repetition Frequencies (PRF), and can be classified into different families, according to their frequency spectrum bandwidth. The bandwidth classification distinguishes the narrowband (also known as hypo band), meso (or moderate) band, ultra-moderate (or sub-hyper) band and hyperband intentional electromagnetic environments 2 .
- Published
- 2019
149. Granitoids and Greenstone Belts of the Pietersburg Block—Witnesses of an Archaean Accretionary Orogen Along the Northern Edge of the Kaapvaal Craton
- Author
-
Adrien Vezinet, Günther Brandl, Armin Zeh, Oscar Laurent, Allan Wilson, Géosciences Environnement Toulouse (GET), Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Observatoire Midi-Pyrénées (OMP), and Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)
- Subjects
geography ,Felsic ,geography.geographical_feature_category ,010504 meteorology & atmospheric sciences ,Archean ,Geochemistry ,[SDU.STU.PE]Sciences of the Universe [physics]/Earth Sciences/Petrography ,Metamorphism ,[SDU.STU]Sciences of the Universe [physics]/Earth Sciences ,010502 geochemistry & geophysics ,01 natural sciences ,Craton ,13. Climate action ,Batholith ,[SDU.STU.GC]Sciences of the Universe [physics]/Earth Sciences/Geochemistry ,[SDU.STU.VO]Sciences of the Universe [physics]/Earth Sciences/Volcanology ,Geology ,Limpopo Belt ,ComputingMilieux_MISCELLANEOUS ,0105 earth and related environmental sciences ,Terrane ,Gneiss - Abstract
The Pietersburg Block (PB), the northernmost terrane of the Kaapvaal Craton, can be subdivided into four Archaean grey gneiss units: Makhutswi-Murchison South (MMS), Groot Letaba-Duivelskloof (GDL), Goudplaats-Hout River (GHR) and Southern Marginal Zone (SMZ). These domains are limited by greenstone belts (Pietersburg, Murchison, Rhenosterkoppies and Giyani) and major shear zones. These lithologies were intruded by a mafic-layered intrusion (the Rooiwater Complex) and voluminous syn- to post-tectonic granitoids forming either small bodies in grey gneisses or voluminous plutons/batholiths. The grey gneisses are made up of Mesoarchaean (3.12–2.85 Ga) and seldom Palaeoarchaean (3.46–3.17 Ga) TTGs formed by melting of metabasaltic rocks at >45 km depth. The greenstone belts consist of Palaeoarchaean (3.46–3.20 Ga) mafic metabasalts, metakomatiites (and intrusive counterparts) and rare Mesoarchaean (2.95–2.84 Ga) felsic volcanics, intercalated with BIF, chert and siliciclastic rocks deposited at 3.05–2.92 Ga in the Murchison belt; 2.88–2.80 Ga in the Pietersburg and Giyani belts; and 2.76–2.71 Ga in the Rhenosterkoppies belt and SMZ. All lithologies were affected by greenschist—to upper amphibolite-facies metamorphism, mainly during Mesoarchaean N–S-directed compression. The 2.97–2.96 Ga Rooiwater Complex and coeval felsic volcanics of the Murchison belt formed through fractionation of mantle-derived magma. Granitoids of the PB include Bt-(Ms-) granites formed at 2.84–2.75 Ga by melting of TTGs (± sediments), and Hbl-Bt-(Cpx-)sanukitoids and Bt-Ep-granitoids at 2.70–2.67 Ga by melting of enriched lithospheric mantle and interactions with the crust during magma ascent. After formation of a Palaeoarchaean (3.46–3.18 Ga) micro-terrane(s) in an island arc and/or oceanic plateau setting, the geodynamic evolution of the PB features a Meso- to Neoarchaean (3.15–2.65 Ga) accretionary orogen formed during protracted southward subduction. The Mesoarchaean evolution began at 3.15–2.97 Ga with the formation of an arc/back-arc system along the northern margin of the proto-Kaapvaal Craton. Subsequently, it was controlled by the docking of the Palaeoarchaean micro-terrane at 2.97–2.84 Ga, causing intense crustal reworking in an Andean-type continental margin setting (2.84–2.73 Ga) and by Neoarchaean (2.73–2.65 Ga) continent-continent collision with a crustal block located farther North, possibly the precursor (>2.7 Ga) rocks of the Central Zone of the Limpopo Belt.
- Published
- 2019
150. Diagnostics of GNSS-based Virtual Balise in Railway Using Embedded Odometry and Track Geometry
- Author
-
Carl Milner, Jérémy Vezinet, Heekwon No, and Ecole Nationale de l'Aviation Civile (ENAC)
- Subjects
Signal Processing (eess.SP) ,[SPI.OTHER]Engineering Sciences [physics]/Other ,Positioning system ,GNSS augmentation ,Computer science ,business.industry ,Real-time computing ,[SPI.MECA]Engineering Sciences [physics]/Mechanics [physics.med-ph] ,Odometer ,Fault detection and isolation ,Odometry ,GNSS applications ,Global Positioning System ,FOS: Electrical engineering, electronic engineering, information engineering ,Track geometry ,Electrical Engineering and Systems Science - Signal Processing ,business ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing - Abstract
International audience; The use of GNSS in the railway sector has been postulated on the notion of a Virtual Balise (VB). The VB-based positioning system works by setting a VB point on the railway track and determining the passage of the VB point using the position solution from the GNSS receiver. Although augmentation systems such as SBAS or GBAS are able to satisfy the integrity requirements of the aviation standards down to the 10-7 level, it is difficult to satisfy the high integrity requirements of the railway sector because firstly the railway users located on the ground are affected by the ground environment such as terrain, buildings and tunnels and secondly because the stringency of the railway sector requirements extends below the 10-9 level. This paper proposes a method to detect faults in the GNSS solution due to satellite failure or local effects. Firstly, requirements for the monitoring performance are carefully derived accounting for the specificities of GNSS, namely that the possibility of consecutive VB faults cannot be discounted. The second contribution of the paper is the proposed detection using both odometry and track geometry of the onboard system. This enables to monitor all three-dimensional solution error so that higher sensitivity for the fault detection can be achieved. Simulations have been performed with both single and dual (GPS, GALILEO) solutions. It has been found that the combinations of metrics are able to achieve very small missed detection probabilities for mean failure rates from 5.0m/s down to 0.03m/s for most dual constellation geometries. The detection performance of the odometer implementation varied according to the heading of the train. On the other hand, when odometry and track geometry are used together, all the three-directional monitors can obtain stable results regardless of the heading.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.